Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 10.16% is 13% below its 5-year average of 11.66%, near the low end of its 5-year range (6.47%–43.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.67% below its 12-month average of 25.19%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.16%.
DEBT TO ASSETS RATIO
10.16%
DEBT TO ASSETS RATIO AVG TTM
25.19%
DEBT TO ASSETS RATIO AVG 3Y
13.43%
DEBT TO ASSETS RATIO AVG 5Y
11.66%
DEBT TO ASSETS RATIO AVG 10Y
7.69%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-59.67%
CURRENT VS 3Y AVG
-24.36%
CURRENT VS 5Y AVG
-12.88%
CURRENT VS 10Y AVG
+32.17%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 672 covered companies
CURRENT VS SECTOR MEDIAN
+10059.55%
vs the sector median at left
MacroGenics, Inc.
Market Cap
$235.25M
Debt to Assets Ratio
10.16%
TTM Avg
25.19%
3Y Avg
13.43%
5Y Avg
11.66%
Market Cap
$242.23M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.53M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.01M
Debt to Assets Ratio
9.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.00M
Debt to Assets Ratio
0.68%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $235.25M | 10.16% | 25.19% | 13.43% | 11.66% |
| BioAge Labs Inc. (BIOA)vs › | $236.96M | 0.01% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $238.57M | 0.33% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $241.56M | 0.00% | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.23M | 0.03% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.53M | 0.15% | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.01M | 9.29% | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $227.20M | 0.75% | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.00M | 0.68% | N/A | N/A | N/A |
| Keros Therapeutics, Inc. (KROS)vs › | $224.97M | 0.05% | N/A | N/A | N/A |
Debt/Assets
10.2%
Debt/Equity
0.82
Current Ratio
2.96
Interest Coverage
-8.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 10.16% |
| 2026-03-31 | 16.76% |
| 2025-12-31 | 41.57% |
| 2025-09-30 | 13.67% |
| 2025-06-30 | 43.81% |
| 2025-03-31 | 16.68% |
| 2024-12-31 | 14.32% |
| 2024-09-30 | 12.89% |
| 2024-06-30 | 16.93% |
| 2024-03-31 | 13.70% |
| 2023-12-31 | 11.38% |
| 2023-09-30 | 10.03% |
| 2023-06-30 | 11.23% |
| 2023-03-31 | 10.06% |
| 2022-12-31 | 12.03% |
| 2022-09-30 | 11.27% |
| 2022-06-30 | 10.64% |
| 2022-03-31 | 8.97% |
| 2021-12-31 | 7.60% |
| 2021-09-30 | 6.77% |
| 2021-06-30 | 6.47% |
| 2021-03-31 | 6.56% |
| 2020-12-31 | 7.72% |
| 2020-09-30 | 7.60% |
| 2020-06-30 | 8.86% |
| 2020-03-31 | 11.19% |
| 2019-12-31 | 9.78% |
| 2019-09-30 | 8.97% |
| 2019-06-30 | 7.28% |
| 2019-03-31 | 6.94% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.08% |
| 2017-09-30 | 0.30% |
| 2017-06-30 | 0.41% |
| 2017-03-31 | 0.55% |
| 2016-12-31 | 0.61% |
| 2016-09-30 | 0.66% |
| 2016-06-30 | 0.70% |
| 2016-03-31 | 1.30% |
| 2015-12-31 | 1.31% |
| 2015-09-30 | 1.35% |
| 2015-06-30 | 2.20% |
| 2015-03-31 | 2.73% |
| 2014-12-31 | 4.60% |
| 2014-09-30 | 4.34% |
| 2014-06-30 | 4.23% |
| 2014-03-31 | 4328524.80% |
| 2013-12-31 | 7509.14% |
| 2013-09-30 | 2928951.60% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
